Moxifloxacin is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

INDICATIONS

FDA

  • Acute bacterial exacerbation of chronic bronchitis (ABECB), Acute bacterial sinusitis
  • Community-acquired pneumonia (including those caused by multi-drug resistant )
  • Uncomplicated skin and skin structure infections (oral and IV). Complicated skin and skin structure infections, including diabetic foot infections (oral and IV)
  • Complicated intra-abdominal infections, including polymicrobial infections such as abscesses. Author’s opinion: due to potential resistance of B. fragilis, use in mild to moderate intra-abdominal infections only. Consider addition of metronidazole for severe infections.
  • Bacterial conjunctivitis (ophthalmic drops)

NON-FDA APPROVED USES

  • Treatment of tuberculosis including MDR and XDR TB (in combination w/ other agents)
  • Treatment of MAC (in combination w/ other agents)

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: November 9, 2011